|
Market Closed -
Other stock markets
|
After hours 05:26:18 am | |||
| 473.09 USD | +0.11% |
|
488.29 | +3.21% |
| Market Cap | 12TCr 11TCr 9.81TCr 9.02TCr 17TCr 11,62800Cr 17TCr 1,17300Cr 46TCr 5,67200Cr 45TCr 44TCr 19,67700Cr | P/E 2026 * |
27x | P/E 2027 * | 23.8x |
|---|---|---|---|---|---|
| Enterprise Value | 11TCr 9.35TCr 8.69TCr 7.99TCr 15TCr 10,29700Cr 15TCr 1,03900Cr 41TCr 5,02300Cr 40TCr 39TCr 17,42500Cr | EV / Sales 2026 * |
8.15x | EV / Sales 2027 * | 7.07x |
| Free-Float |
99.8% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | +0.11% | ||
| 1 week | -2.66% | ||
| Current month | -4.76% | ||
| 1 month | +1.00% | ||
| 3 months | +8.73% | ||
| 6 months | +1.00% | ||
| Current year | +4.35% |
| 1 week | 465 |  | 491.23 |
| 1 month | 465 | | 533.67 |
| Current year | 412.27 | | 533.67 |
| 1 year | 362.5 | | 533.67 |
| 3 years | 340.2 | | 533.67 |
| 5 years | 176.36 | | 533.67 |
| 10 years | 71.46 | | 533.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 10/04/2019 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/07/26 | Free | Director | 32 | 0.0000% | ||
| 15/07/26 | Free | Director | 100 | 0.0000% | ||
| 02/07/26 | Sell | General Counsel | -1,500 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.11% | -2.66% | -0.81% | +30.52% | 12TCr | |
| +1.97% | +1.43% | +48.44% | +156.66% | 1,05700Cr | |
| +1.42% | +3.72% | +53.32% | +52.34% | 62TCr | |
| +1.43% | +0.99% | +34.83% | +78.74% | 45TCr | |
| +0.96% | +5.12% | +32.52% | +28.45% | 34TCr | |
| -0.42% | +1.52% | +35.68% | +39.76% | 30TCr | |
| -0.69% | -0.10% | +15.37% | +16.72% | 26TCr | |
| -0.52% | -3.21% | -28.58% | -41.95% | 22TCr | |
| +1.49% | -0.02% | +20.14% | +58.21% | 20TCr | |
| +0.40% | -3.99% | +15.23% | +62.28% | 16TCr | |
| Average | +0.61% | +0.43% | +22.61% | +48.17% | 37.34TCr | |
| Weighted average by Cap. | +1.04% | +1.43% | +33.82% | +74.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.3TCr 1.15TCr 1.07TCr 980.36Cr 1.84TCr 1,26300Cr 1.87TCr 13TCr 4.97TCr 62TCr 4.9TCr 4.79TCr 2,13800Cr | 1.43TCr 1.26TCr 1.17TCr 1.08TCr 2.02TCr 1,38900Cr 2.06TCr 14TCr 5.47TCr 68TCr 5.39TCr 5.27TCr 2,35100Cr |
| Net income | 451.83Cr 397.39Cr 369.17Cr 339.53Cr 636.74Cr 44TCr 648.15Cr 4.41TCr 1.72TCr 21TCr 1.7TCr 1.66TCr 74TCr | 513.57Cr 451.68Cr 419.61Cr 385.93Cr 723.74Cr 50TCr 736.71Cr 5.02TCr 1.96TCr 24TCr 1.93TCr 1.89TCr 84TCr |
| Net Debt | -1.37TCr -1.21TCr -1.12TCr -1.03TCr -1.94TCr -1,33100Cr -1.97TCr -13TCr -5.24TCr -65TCr -5.16TCr -5.05TCr -2,25200Cr | -1.86TCr -1.64TCr -1.52TCr -1.4TCr -2.62TCr -1,80200Cr -2.67TCr -18TCr -7.09TCr -88TCr -6.99TCr -6.84TCr -3,05000Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | $473.09 | +0.11% | 13,06,125 |
| 22/26/22 | $472.57 | -1.96% | 12,89,189 |
| 21/26/21 | $482.00 | +0.31% | 11,07,414 |
| 20/26/20 | $480.50 | -1.06% | 11,01,762 |
| 17/26/17 | $485.65 | -0.08% | 15,68,122 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
